Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion type Assertion NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_head.
- NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion description "[Despite an initial response to EGFR tyrosine kinase inhibitors (EGFR-TKI) in EGFR mutant lung cancer, most patients eventually become resistant and result in treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_provenance.
- NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion evidence source_evidence_literature NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_provenance.
- NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion SIO_000772 22173954 NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_provenance.
- NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion wasDerivedFrom befree-2016 NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_provenance.
- NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_assertion wasGeneratedBy ECO_0000203 NP947094.RAM-l5dTgM-tqsSYj9qv96fuEGvQwrC7mW7-qcAfhrKl4130_provenance.